Diana Juvinao-Quintero, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fetal Blood | 4 | 2023 | 1318 | 1.060 |
Why?
|
DNA Methylation | 7 | 2023 | 4286 | 1.050 |
Why?
|
Hyperglycemia | 3 | 2023 | 1373 | 1.000 |
Why?
|
Diabetes, Gestational | 3 | 2023 | 1184 | 0.670 |
Why?
|
Blood Cells | 1 | 2021 | 309 | 0.660 |
Why?
|
Pregnant Women | 1 | 2021 | 568 | 0.560 |
Why?
|
CpG Islands | 4 | 2021 | 1172 | 0.460 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2023 | 11725 | 0.390 |
Why?
|
Blood Glucose | 3 | 2023 | 6256 | 0.390 |
Why?
|
Insulin Resistance | 2 | 2023 | 3864 | 0.350 |
Why?
|
Genome-Wide Association Study | 3 | 2023 | 12261 | 0.320 |
Why?
|
Pregnancy Complications | 1 | 2021 | 2861 | 0.280 |
Why?
|
Epigenesis, Genetic | 4 | 2022 | 3647 | 0.250 |
Why?
|
Cortisone | 1 | 2023 | 89 | 0.220 |
Why?
|
Hair | 2 | 2023 | 483 | 0.220 |
Why?
|
Pituitary-Adrenal System | 2 | 2023 | 553 | 0.220 |
Why?
|
Hypothalamo-Hypophyseal System | 2 | 2023 | 703 | 0.210 |
Why?
|
Carnitine O-Palmitoyltransferase | 1 | 2021 | 86 | 0.190 |
Why?
|
European Union | 1 | 2021 | 158 | 0.180 |
Why?
|
Pregnancy | 6 | 2023 | 29144 | 0.170 |
Why?
|
Quantitative Trait, Heritable | 1 | 2021 | 544 | 0.160 |
Why?
|
Hydrocortisone | 2 | 2023 | 1826 | 0.160 |
Why?
|
Pregnancy Trimester, Second | 1 | 2021 | 732 | 0.160 |
Why?
|
Chile | 3 | 2023 | 237 | 0.150 |
Why?
|
Glucose Tolerance Test | 1 | 2021 | 1150 | 0.150 |
Why?
|
Histone Deacetylases | 1 | 2021 | 728 | 0.140 |
Why?
|
Epigenomics | 1 | 2021 | 903 | 0.140 |
Why?
|
Cholesterol | 1 | 2023 | 2917 | 0.120 |
Why?
|
Suicidal Ideation | 1 | 2022 | 1248 | 0.110 |
Why?
|
Genetic Association Studies | 1 | 2021 | 2703 | 0.100 |
Why?
|
Insulin | 2 | 2023 | 6580 | 0.090 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2023 | 2214 | 0.090 |
Why?
|
Repressor Proteins | 1 | 2021 | 3023 | 0.090 |
Why?
|
Carrier Proteins | 1 | 2021 | 5021 | 0.070 |
Why?
|
Liver Neoplasms | 1 | 2023 | 4253 | 0.070 |
Why?
|
Longitudinal Studies | 1 | 2023 | 13989 | 0.070 |
Why?
|
Cross-Sectional Studies | 3 | 2023 | 25043 | 0.070 |
Why?
|
Female | 8 | 2023 | 380194 | 0.070 |
Why?
|
Humans | 12 | 2023 | 744343 | 0.060 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2020 | 3255 | 0.060 |
Why?
|
MicroRNAs | 1 | 2021 | 3752 | 0.060 |
Why?
|
Infant, Newborn | 2 | 2022 | 25625 | 0.060 |
Why?
|
Adult | 7 | 2023 | 214055 | 0.060 |
Why?
|
Prevalence | 1 | 2021 | 15226 | 0.060 |
Why?
|
Case-Control Studies | 1 | 2021 | 21746 | 0.060 |
Why?
|
Hypertension | 1 | 2023 | 8480 | 0.050 |
Why?
|
Male | 4 | 2023 | 350118 | 0.050 |
Why?
|
Prospective Studies | 2 | 2023 | 53288 | 0.040 |
Why?
|
Chromatography, Liquid | 1 | 2023 | 976 | 0.040 |
Why?
|
Risk Factors | 2 | 2022 | 72290 | 0.040 |
Why?
|
Tandem Mass Spectrometry | 1 | 2023 | 1157 | 0.040 |
Why?
|
Child | 1 | 2023 | 77709 | 0.030 |
Why?
|
Young Adult | 1 | 2021 | 56430 | 0.030 |
Why?
|
Psychometrics | 1 | 2022 | 3002 | 0.030 |
Why?
|
Pain Measurement | 1 | 2022 | 3420 | 0.030 |
Why?
|
Aged | 2 | 2021 | 163280 | 0.020 |
Why?
|
Anxiety Disorders | 1 | 2022 | 2690 | 0.020 |
Why?
|
Middle Aged | 2 | 2021 | 213383 | 0.020 |
Why?
|
Genotype | 1 | 2023 | 12951 | 0.020 |
Why?
|
Stress, Psychological | 1 | 2023 | 4245 | 0.020 |
Why?
|
Blood Pressure | 1 | 2023 | 8554 | 0.020 |
Why?
|
Body Mass Index | 1 | 2023 | 12720 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2022 | 19905 | 0.010 |
Why?
|
Phenotype | 1 | 2020 | 16365 | 0.010 |
Why?
|
Infant | 1 | 2023 | 35136 | 0.010 |
Why?
|
Quality of Life | 1 | 2022 | 12804 | 0.010 |
Why?
|
Child, Preschool | 1 | 2023 | 41006 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39050 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 40561 | 0.010 |
Why?
|